NAPSA and non-small cell lung carcinoma: Moreover, napsin-A (NAPSA) and anterior gradient protein 2 homolog (AGR2) were proposed as stage-related proteins based on label-free SRM quantification in FFPE samples from stage IA and IIIA NSCLC patients [15].